Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Sam Altman and Arianna Huffington’s AI Health Revolution

by Team Lumida
July 9, 2024
in AI, Health and Longevity
Reading Time: 3 mins read
A A
0
Sam Altman and Arianna Huffington’s AI Health Revolution

Source: Decrypt

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  • OpenAI and Thrive Global launch Thrive AI Health to extend health spans.
  • AI health coach offers personalized advice using biometrics and lifestyle data.
  • Partnership focuses on health equity, targeting underserved populations.

What Happened?

OpenAI’s Sam Altman and Thrive Global’s Arianna Huffington announced the launch of Thrive AI Health, a new initiative aimed at revolutionizing healthcare using artificial intelligence. Thrive AI Health will develop an AI health coach offering personalized recommendations based on biometrics and lifestyle habits.

The platform will integrate Thrive’s behavior change methodology, focusing on microhabit changes. DeCarlos Love, a former Google executive, will lead as CEO. The Alice L. Walton Foundation supports this venture, and key partnerships include Stanford Medicine and the Rockefeller Neuroscience Institute.

Why It Matters?

AI in healthcare promises to address critical issues like chronic disease management and health equity. With 130 million Americans diagnosed with chronic conditions, Thrive AI Health aims to provide tailored health recommendations, potentially reducing the prevalence of chronic diseases and improving quality of life.

As Arianna Huffington emphasized, AI can democratize access to health benefits, similar to how the New Deal transformed physical infrastructure. By leveraging AI, Thrive AI Health could offer scalable, precise health interventions that human coaches cannot match.

What’s Next?

The inaugural team at Thrive AI Health is moving swiftly to customize and test the AI health coach. They plan to make the product available to Thrive Global’s employer base and expand through self-insured employers and pharmaceutical companies. As they scale, the focus will remain on maintaining robust privacy and security measures.

Partnerships with academic institutions will further aid in refining and validating the AI coach’s effectiveness. Investors and stakeholders should watch for how this platform could become integral to future health infrastructure, especially in underserved communities.

Source: Fortune Well
Tags: AI health coachArianna HuffingtonSam Altman
Previous Post

Bullish Bitcoin: Why Market Experts Predict a Major BTC Comeback

Next Post

Crackdown on Property Fraud Shakes $4.7 Trillion Real Estate Market

Recommended For You

Nvidia Plans Shanghai R&D Center to Navigate U.S.-China Tech Tensions

by Team Lumida
2 days ago
Nvidia CEO Jensen Huang Sells $169M in Shares Amid AI Boom

Key Takeaways: Powered by lumidawealth.com Nvidia is opening a research and development (R&D) center in Shanghai to better understand Chinese customer needs while complying with U.S. export controls. The...

Read more

Musk’s xAI Blames Unauthorized Tampering for Controversial ‘White Genocide’ Responses

by Team Lumida
3 days ago
Musk and Trump’s Friendship: What It Means for the EV Market

Key Takeaways: Powered by lumidawealth.com Elon Musk’s AI chatbot, Grok, attributed its controversial responses about “white genocide” in South Africa to unauthorized modifications in its system. xAI has reversed...

Read more

CoreWeave Reports Fivefold Revenue Growth but Warns of Margin Pressure Amid Increased Investments

by Team Lumida
4 days ago
CoreWeave Reports Fivefold Revenue Growth but Warns of Margin Pressure Amid Increased Investments

Key Takeaways: Powered by lumidawealth.com CoreWeave’s Q1 revenue surged over fivefold to $981.6 million, driven by strong customer demand for its AI-focused cloud infrastructure. The company projects 2025 revenue...

Read more

U.S. Rescinds AI Diffusion Rule, Boosting Nvidia and Global AI Partnerships

by Team Lumida
5 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Key Takeaways: Powered by lumidawealth.com The U.S. Department of Commerce has scrapped the Biden-era "AI Diffusion Rule," which restricted chip exports to countries like India and Switzerland, citing its...

Read more

AI Search Startup Perplexity Hits $14 Billion Valuation in $500 Million Funding Round

by Team Lumida
6 days ago
AI Search Startup Perplexity Hits $14 Billion Valuation in $500 Million Funding Round

Key Takeaways: Powered by lumidawealth.com Perplexity AI is raising $500 million in a funding round led by Accel, boosting its valuation to $14 billion, a 50% increase from late...

Read more

SoftBank’s $100 Billion Stargate AI Project Faces Delays Amid Tariff and Market Uncertainty

by Team Lumida
1 week ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways: Powered by lumidawealth.com SoftBank’s ambitious $100 billion Stargate AI infrastructure project, launched with OpenAI, is facing delays due to tariff concerns, rising costs, and market volatility. Financing...

Read more

AI-Driven Drug Firm METiS Eyes $200 Million Hong Kong IPO Amid Growing Biotech Momentum

by Team Lumida
1 week ago
AI Investment Boom: How Tech Giants Are Leading the Charge

Key Takeaways: Powered by lumidawealth.com METiS Pharmaceuticals, an AI-driven drug discovery and delivery firm, is considering a Hong Kong IPO to raise up to $200 million by the end...

Read more

Trump Administration to Overhaul AI Chip Export Rules, Easing Restrictions for U.S. Allies

by Team Lumida
2 weeks ago
AI Investment Boom: How Tech Giants Are Leading the Charge

Key Takeaways: Powered by lumidawealth.com The Trump administration plans to replace the Biden-era "AI diffusion" rule, which imposed limits on AI chip exports to countries like India, Switzerland, Mexico,...

Read more

OpenAI Launches Global Initiative to Help Countries Build AI Infrastructure

by Team Lumida
2 weeks ago
OpenAI’s Secret Weapon Against AI Cheating: Why It’s Still Under Wraps

Key Takeaways: Powered by lumidawealth.com OpenAI has announced a new program, OpenAI for Countries, to assist national governments in building AI infrastructure, including data centers and customized AI solutions...

Read more

Mark Zuckerberg Envisions a Future Where AI Friends Outnumber Human Companions

by Team Lumida
2 weeks ago
a white square with a blue logo on it

Key Takeaways: Powered by lumidawealth.com Meta CEO Mark Zuckerberg is promoting a vision where AI plays a central role in human relationships, offering AI friends, therapists, and business agents...

Read more
Next Post
low angle photo of city high rise buildings during daytime

Crackdown on Property Fraud Shakes $4.7 Trillion Real Estate Market

Man on his Surface laptop at home with Christmas decorations around

AI PCs: The Future of Computing or Just Hype?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

black and silver mercedes benz logo

Hyundai Shares Surge After $21 Billion U.S. Investment Plan to Counter Trump Tariffs

March 25, 2025
turned-on drone

The New Frontier: Underwater Drone Warfare

December 16, 2024
Alphabet $GOOGL Q2 2024 Results

Google Challenges $4.3B EU Android Fine in Final Appeal

January 28, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018